Type 2 diabetes mellitus (DM) is associated with an increased risk of cardiovascular disease
(CVD). Atrial fibrillation (AF) and stroke are both forms of CVD that have major …

Type 2 diabetes (T2D) is an independent risk factor of stroke and systemic embolism in
patients with atrial fibrillation (AF), and T2D patients with AF‐associated stroke seem to have …

Aims This study aims to describe both management and prognosis of patients with diabetes
mellitus (DM) and newly diagnosed atrial fibrillation (AF), overall as well as by antidiabetic …

Abstract Background The Mobile Health Technology for Improved Screening and Optimized
Integrated Care in AF (mAFA‐II) prospective randomized trial showed the efficacy of a …

Background and Purpose: Comparative effectiveness and safety of oral anticoagulants in
patients with atrial fibrillation and high polypharmacy are unknown. Methods: We used …

Aims Atrial fibrillation (AF) and diabetes mellitus (DM) are both associated with adverse
clinical events, but the associations have not been fully elucidated, particularly with …

Whether there are differences in direct oral anticoagulants efficacy and safety in patients
with atrial fibrillation (AF) combined with hypertension is unclear. We therefore conducted a …

Whether and how insulin counteracts the cytotoxic effects of hypoxia and improves
cardiomyocyte viability remains unclear. To achieve this aim, cultured neonatal rat …

Purpose Patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention
(PCI) are a high-risk subset of patients, whose optimal antithrombotic treatment strategy …

Background There are limited data on the association of diabetes duration and glycemic
control with stroke risk in atrial fibrillation (AF). Our objective was to study the association of …